Andrew B. Nixon

A leave-one-out cross-validation SAS macro for the identification of markers associated with survival

Anuradha Bulusu, Herbert Pang, Christel Rushing, 2015, Comput. Biol. Medicine.

Results of a phase I study of bevacizumab (BV), everolimus (EV), and erlotinib (E) in patients with advanced solid tumors

Andrew B. Nixon, Herbert Hurwitz, Daohai Yu, 2007 .